Skip to content
The Nexus
HEALTHJul 2 · 23:41 UTCFOX 32 CHICAGO[email protected] (Stephanie Weaver)

FDA authorizes 20 ZYN nicotine pouches to be marketed with modified risk claim

The FDA authorized 20 ZYN nicotine pouches to carry a modified risk claim. This allows the product to be marketed with a label indicating reduced health risks compared to traditional tobacco products.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting